Article Information
History
- November 11, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Vladimir V. Ivanov1,†,
- Anton B. Zakharov1,
- Dmytro O. Anokhin1,
- Olha O. Mykhailenko2,
- Sergiy M. Kovalenko1,
- Larysa V. Yevsieieva1,
- Victoriya A. Georgiyants2,*,
- Michal Korinek3,4,†,
- Yu-Li Chen5,
- Shu-Yen Fang4,6,
- Mohamed El-Shazly7,
- Tsong-Long Hwang4,5,8,* and
- Oleg M. Kalugin1
- 1School of Chemistry, V. N. Karazin Kharkiv National University, Kharkiv 61077, Ukraine
- 2Department of Pharmaceutical Chemistry, National University of Pharmacy, Kharkiv 61002, Ukraine
- 3Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
- 4Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
- 5Graduate Institute of Health Industry Technology and Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33303, Taiwan
- 6Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
- 7Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt
- 8Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan
- ↵*Corresponding authors: vgeor{at}nuph.edu.ua (V.A.G.); htl{at}mail.cgu.edu.tw (T.-L.H.); Tel.: +380572-67-91-97 (V.G.); +886-3-2118800 (ext. 5523) (T.-L.H.)
↵† These authors contributed equally to this work
Posted November 11, 2024.
DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHES
